PARIS–Cellectis (Paris:ALCLS) and Genoway indicate that the sublicense agreement dated September 7, 2001, relating to the patents and patent applications belonging to the pool WO90/11354 has been terminated as of December 30, 2008. Cellectis and Genoway have agreed on the consequences of such termination of the sublicense agreement, allowing Genoway to deliver the orders placed […]
SAN DIEGO — Volcano Corporation (Nasdaq: VOLC) today announced that the jury in the litigation filed by Lightlab Imaging, Inc. on January 7, 2009 in the Superior Court of Massachusetts, Suffolk County reached a verdict against Volcano and its wholly owned subsidiary, Axsun Technologies. In December 2008, Volcano acquired Axsun, which had an agreement to […]
SAVANNAH, Ga.–Health Discovery Corporation (OTCBB: HDVY) announced today that the Company has received the final payment that was due under the agreement that settled the Company’s patent infringement lawsuit against Vermillion (Pink Sheets: VRML), formerly known as Ciphergen Biosystems, Inc. In 2006, Health Discovery Corporation sued Ciphergen Biosystems in Federal District Court for infringement of […]
SOUTH SAN FRANCISCO, Calif.–Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in […]
GOTHENBURG, Sweden — Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon’s state-of-the-art […]
CAMBRIDGE, Mass.–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the German Patent Office has upheld the “Kreutzer-Limmer I” ’235 (DE 10066235) patent in oral proceedings held before the Opposition Board. The patent was upheld in an amended form and the opponents’ request to revoke the patent was rejected. The ’235 […]
SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM), announced today the entry of a settlement agreement which will resolve the consolidated securities class action lawsuits, In re Sequenom, Inc. Securities Litigation, Master File No: 3:09-cv-00921-LAB-WMC. The defendants have agreed to pay $14 million, which will be funded by insurance proceeds. Additionally the company has agreed to […]
BOULDER, Colo.–The Shuman Law Firm today announced that it is investigating potential breaches of fiduciary duty and other violations of state law on behalf of shareholders of Zygo Corporation (Nasdaq: ZIGO – News) (“Carter’s” or the “Company”) related to an unsolicited purchase offer the Company received from II-VI Incorporated (“II-VI”) to acquire all of the […]
Litigation with HandyLab Settled HOPKINTON, Mass — Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of life sciences tools, announced today that Becton, Dickinson and Company (BD), has acquired a license to Caliper’s microfluidics patent portfolio. “We are pleased that Becton Dickinson is leveraging the strength of our microfluidics intellectual property to facilitate the […]
NEW YORK–Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of the common stock of Zygo Corporation (“Zygo” or the “Company”) (Nasdaq: ZIGO – News) for possible breaches of fiduciary duty and other violations of state law by the Company’s Board of Directors in connection […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
